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Abstract
Lavender Foal Syndrome (LFS) is a lethal inherited disease of horses with a suspected autosomal recessive mode of
inheritance. LFS has been primarily diagnosed in a subgroup of the Arabian breed, the Egyptian Arabian horse. The
condition is characterized by multiple neurological abnormalities and a dilute coat color. Candidate genes based on
comparative phenotypes in mice and humans include the ras-associated protein RAB27a (RAB27A) and myosin Va (MYO5A).
Here we report mapping of the locus responsible for LFS using a small set of 36 horses segregating for LFS. These horses
were genotyped using a newly available single nucleotide polymorphism (SNP) chip containing 56,402 discriminatory
elements. The whole genome scan identified an associated region containing these two functional candidate genes. Exon
sequencing of the MYO5A gene from an affected foal revealed a single base deletion in exon 30 that changes the reading
frame and introduces a premature stop codon. A PCR–based Restriction Fragment Length Polymorphism (PCR–RFLP) assay
was designed and used to investigate the frequency of the mutant gene. All affected horses tested were homozygous for
this mutation. Heterozygous carriers were detected in high frequency in families segregating for this trait, and the frequency
of carriers in unrelated Egyptian Arabians was 10.3%. The mapping and discovery of the LFS mutation represents the first
successful use of whole-genome SNP scanning in the horse for any trait. The RFLP assay can be used to assist breeders in
avoiding carrier-to-carrier matings and thus in preventing the birth of affected foals.
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Introduction
Heritable disorders affect many domestic species, including the
horse. In the Arabian breed of horse a neurological disorder has
been reported that is lethal soon after birth [1]. Affected foals can
display an array of neurological signs including tetanic-like
seizures, opisthotonus, stiff or paddling leg movements and
nystagmus (Figure 1) [2]. Mild leucopenia is sometimes observed
[2,3]. These neurologic impairments prevent the foal from
standing and nursing normally and, if not lethal on their own,
are often cause for euthanasia. In addition to these abnormalities,
affected foals possess a characteristic diluted ‘‘lavender’’ coat color.
This resulting coat color, variously described as pale gray, pewter,
and light chestnut, as well as lavender, has coined the name
‘‘Lavender Foal Syndrome’’ (LFS) [2]. Also called ‘‘Coat Color
Dilution Lethal’’ [2], there is currently no treatment for LFS
available. Additionally, initial diagnosis can be difficult as the
clinical signs of LFS can easily be confused with a number of
neonatal conditions including neonatal maladjustment syndrome
and encephalitis [2]. The inheritance of Lavender Foal Syndrome
is suspected to be recessive, although extensive pedigree analysis
has not, to date, been published. Outwardly healthy horses can
sire lethally affected foals; therefore a recessive mode of
inheritance for LFS is most likely.
Historically developed by the Bedouin tribesman on the
Arabian Peninsula, the Arabian horse is one of the oldest
recognized breeds of horse. Valued for its beauty and athleticism,
the Arabian has contributed to the development of many light
horse breeds, most notably the Thoroughbred, a breed used
extensively in horse racing across the world [4]. The majority of
documented cases of Lavender Foal Syndrome have been reported
in the Egyptian Arabian, a sub-group of the Arabian breed found
originally in Egypt but extensively exported and popular in the
United States. Egyptian Arabians have their own registry,
although they are also part of the main Arabian studbook. It is
estimated that there are 49,000 living registered Egyptian
PLoS Genetics | www.plosgenetics.org 1 April 2010 | Volume 6 | Issue 4 | e1000909Arabians worldwide (personal communication, Beth Minnich,
Pyramid Society). Identifying the genetic basis of this condition
and developing a diagnostic test for the LFS allele will enable
breeders to make more informed selection of mating pairs, thus
avoiding the production of affected foals and potentially lowering
the frequency of this allele in the population, without wholesale
culling of valuable stock.
Over the past 15 years the Horse Genome Project has produced
several generations of analytical and diagnostic resources (genetic
tools) that permit interrogation of polymorphisms across the entire
equine genome [5,6]. Previous mapping efforts using ,300
microsatellite markers yielded results for several heritable diseases
(for examples see [7,8]). However, this small number of markers
limited genetic studies in the horse to simple traits in closely related
families with fairly large numbers of samples. The recently
completed 6.8x whole genome sequence of the horse and the
associated identification of approximately 1.5 million Single
Nucleotide Polymorphisms (SNPs) located throughout the horse
genomic sequence [9] has enabled the construction of a 56,402
element SNP chip for rapid whole genome scanning (Equine
SNP50, Illumina, San Diego, CA). SNP-based whole genome
association studies have proven exceptionally successful when
studying simple mendelian traits in domesticated species. Two
notable examples can be found in studies of coat traits in the dog
[10] and recessive diseases of cattle [11].
Previously described mutations in mice and humans provide
several comparative phenotypes similar to Lavender Foal
Syndrome. Two genes in particular, Ras-associated protein
RAB27a (RAB27A) and myosin Va (MYO5A), yield phenotypes
with striking parallels to LFS. These two proteins, along with
melanophilin (MLPH) are part of a transportation complex
responsible for the trafficking of melanosomes to the periphery
of the cell where they are transferred to the keratinocyte (reviewed
in [12]). The myosin Va transport complex is also utilized in the
dendrite of the neuron where it has been shown to move various
cargo, including mRNAs, glutamate receptors, and secretory
granules [13,14]. Disruption of these diverse functions could
explain the constellation of defects observed in RAB27A and
MYO5A mutants. In mice, 71 mutations in MYO5A and 106 in
RAB27A have been recorded in the MGD database [15]. In
humans, several unique recessive mutations in these two genes
have been shown to cause similar disorders. The severity of the
phenotype, known as Griscelli syndrome, varies with the gene and
location of the mutation [16]. Griscelli syndromes have been
divided in to three categories based on the gene responsible;
MYO5A in type 1, RAB27A in type 2, and MLPH in type 3 [17].
There are subtle differences in the phenotype of each of these
subtypes. For example, RAB27A mutations in both human and
mouse disrupt granule exocytosis in T lymphocytes. This leads to
immunodeficiency and leukocyte infiltration in to vital organs,
including the brain. Thus, although neurological defects are often
present in RAB27A mutants they are usually secondary to this
infiltration [17]. In contrast, MYO5A mutants exhibit a primary
neurologic dysfunction and have normal immune function. Based
on this distinction MYO5A was chosen as the primary candidate
gene for Lavender Foal Syndrome.
Results
Pedigree Analysis
Pedigree data from the six affected foals available at the time of
genotyping supported a recessive mode of inheritance. A single
common ancestor was identified six to eight generations from
these six affected foals (Figure S1). This common ancestor is
present on both sides of the pedigree in each foal. This stallion
may represent a founder among this group and this convergence
in the pedigree supports identity by descent for the LFS mutation.
Average inbreeding (Fi) was 0.0861 for affected foals, versus
0.0394 for parents of foals. The extended pedigree also allowed for
the calculation of the coancestry coefficient between each living
relative and the nearest affected foal in the pedigree. Based on this
calculation we predicted that the frequency of the LFS allele would
be 0.42 among the 30 relatives used for genotyping.
Association Mapping
Genotypic association tests using the six affected foals and their
30 healthy relatives revealed a single region on chromosome 1
(ECA1) with statistical significance above that of the rest of the
genome (Figure 2). These 14 highly significant SNPs encompassed
a region spanning 10.5 Mb (ECA1:129228091 to 139718117).
Although extensive inbreeding and relatedness between affected
individuals produced a high number of coincidentally significant
(p,0.05) SNPs across the genome, the high peak significance of
Figure 1. A foal with Lavender Foal Syndrome demonstrating
opisthotonus, one cardinal neurological sign of the disorder.
(Photo courtesy of Dr. Yael Giora).
doi:10.1371/journal.pgen.1000909.g001
Author Summary
Genetic disorders affect many domesticated species,
including the horse. In this study we have focused on
Lavender Foal Syndrome, a seizure disorder that leads to
suffering and death in foals soon after birth. A recessively
inherited disorder, its occurrence is often unpredictable
and difficult for horse breeders to avoid without a
diagnostic test for carrier status. The recent completion
of the horse genome sequence has provided new tools for
mapping traits with unprecedented resolution and power.
We have applied one such tool, the Equine SNP50
genotyping chip, to a small sample set from horses
affected with Lavender Foal Syndrome. A single genetic
location associated with the disorder was rapidly identified
using this approach. Subsequent sequencing of functional
candidate genes in this location revealed a single base
deletion that likely causes Lavender Foal Syndrome. From
a practical standpoint, this discovery and the development
of a diagnostic test for the LFS allele provides a valuable
new tool for breeders seeking to avoid the disease in their
foal crop. However, this work also illustrates the utility of
whole-genome association studies in the horse.
A MYO5A Deletion Leads to Lavender Foal Syndrome
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evidence for association. In total there were 14 SNPs at this locus
that were more significantly associated with the LFS trait than any
other region in the genome. The twelve LFS bearing chromo-
somes from the six affected horses represented only four unique
haplotypes for this 10 Mb candidate region. These four haplotypes
possessed one large block of 27 SNPs in common. This 1.6 Mb
region was homozygous in all six affected horses and heterozygous
in obligate carriers as well as many of the living relatives, as was
predicted by the coancestry in the pedigree. The linkage
disequilibrium (LD) structure and p-values in this likely location
for a recessive mutation are plotted in Figure 3. Only 10 Ensembl
Gene Predictions fell within this region, including MYO5A, but not
RAB27A (UCSC Genome Browser [9]).
Population Structure
Genome-wide observed homozygosity from the genotypes
obtained using the EquineSNP50 chip was on average 65.14%.
This was much higher than expected considering the homozygos-
ity of the inbred mare chosen for whole genome sequencing was
estimated at only 46% [9]. The ten founder Egyptian Arabian
individuals from this study, as well as an additional 10 unrelated
individuals from the Thoroughbred, Arabian (non-Egyptian) and
Saddlebred breeds were used to calculate average genome-wide
Figure 2. P-values (,0.05) for SNP association with Lavender Foal Syndrome. Individual chromosomes are represented with various colors
in numerical order. The region with the most significant P-values (highlighted with a yellow bar) falls on the p arm of ECA1.
doi:10.1371/journal.pgen.1000909.g002
Figure 3. Linkage disequilibrium plot of the homozygous region associated with LFS. Plotted at the top are the corresponding p-values
for these 27 SNPs. The yellow shaded box highlights the SNP closest to MYO5A. Red diamonds represent D’ values equal to 1, lower values of D’ are
given in within the boxes in shades of pink to white, while non-significant associations are blue.
doi:10.1371/journal.pgen.1000909.g003
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the Egyptian was similar to that of the Thoroughbred, a breed
with a long history of a closed studbook and relatively small
foundation population. LD in the Egyptian was also much longer
than that of the Arabian population as a whole, which was most
similar to the Saddlebred. The Saddlebred breed registry was
closed in 1917 and derived from fairly diverse types of horse
suitable for use as transportation under saddle and in harness.
Candidate Gene Sequencing
Individual PCR amplification and sequencing of the 39 exons of
MYO5A from a LFS affected foal revealed three SNPs and one
polymorphic microsatellite in intronic sequence, as well as a single
base deletion in exon 30 of MYO5A (Table 1). This deletion was
further confirmed by sequencing in a second foal and its
heterozygous parents (Figure 4). The deletion is termed ECA1
g.138235715del per Human Genome Variation Society (http://
www.hgvs.org/mutnomen/) nomenclature. This deletion changes
the reading frame, creating a premature stop codon in the
translation of exon 30, 12 amino acids following the mutation. A
multiple alignment of the predicted LFS exon 30 amino acid
sequence, as well as the wild type sequence from eight species,
shows that this region of the myosin Va protein is highly conserved
(Figure S3). The four intronic polymorphisms were not predicted
to change the function of myosin Va and were therefore not
investigated further.
Association and Frequency Estimates
We designed a PCR-RFLP assay using the Fau I restriction
enzyme to detect this deletion (Figure S4). Digestion of the PCR
product produces a positive control fragment of 289 bp in all
genotypes. Presence of the deletion abolishes a Fau I site, changing
the normal pattern of a 386 bp and a 90 bp fragment in to a single
476 bp product. All seven affected foals (the six originally
submitted for mapping plus one additional obtained after mapping
was completed) were homozygous for the deletion (Table 2). Eight
out of the 14 parents of these affected foals were available for
sampling and all carried the deletion. Among 23 relatives of
affected foals 16 were identified as carriers of the deletion. A
sample group of 114 Arabian horses was tested to provide a rough
estimate of the frequency of the MYO5A exon 30 deletion, and
therefore Lavender Foal Syndrome, in the breed as a whole
(Table 3). 10.3% of Egyptian Arabians (six out of 58 horses) and
1.8% of non-Egyptian Arabians (one out of 56 horses) were
identified as carriers.
Discussion
Here we describe the first successful use of the EquineSNP50
genotyping platform in identification of the mutation responsible
for a genetic disorder in the horse. We have described a frameshift
mutation in the MYO5A gene that leads to Lavender Foal
Syndrome in the Egyptian Arabian breed of horse. This task was
made more challenging by the small number (six) of DNA samples
from available affected foals. We improved our chances of success
by using pedigree data to select control samples from the extended
family and by utilizing a genotype association rather than allelic
association statistic in combination with identification of regions of
homozygosity.
The extreme predicted impact on function resulting from the
single base deletion in MYO5A exon 30 makes it a very logical
cause of LFS. Indeed, an alignment of MYO5A exon 30 amino acid
sequences from 8 diverse species shows that the exon is completely
conserved in horses, humans, mice, dogs and cattle and contains
only a few changes in the possum, chicken, and zebrafish (Figure
S3). As LFS affected foals do not have an immunodeficiency
consistent with RAB27A mutations, and the genomic region
containing this gene was not inherited as predicted by our
recessive model, it is doubtful that this gene plays a role in
Lavender Foal Syndrome.
The newly discovered deletion in exon 30 of MYO5A leads to a
frame shift and premature termination of transcription. Loss of the
Figure 4. Discovery of the Lavender Foal Syndrome–associated
single base deletion by sequencing. Pictured are aligned
chromatograms from horses with each of the three genotypes. The
deletion occurs at the base marked with the vertical line, causing a
mixed sequence from this point forward in the carrier.
doi:10.1371/journal.pgen.1000909.g004
Table 1. Polymorphisms identified in the MYO5A sequence.
HGVS Nomenclature Within Gene Location Type
g.138148824A.G Intron 3+100 SNP
g.138168098G.A Intron 6+189 SNP
g.138230294C.T Intron 27–156 SNP
g.138235715del
a Exon 30+148 Frameshift
g.138253441GT(10_12) Intron 35–79 (GT) satellite
(a- LFS associated polymorphism).
doi:10.1371/journal.pgen.1000909.t001
Table 2. Association of Lavender Foal Syndrome with ECA1
g.138235715del.
Genotypes
a +/+ +/2 2/2
Affected (Homozygotes) 0 0 7
Parents (Carriers) 0 8 0
Other Relatives (Unknown Genotype) 7 16 0
Total 7 24 7
(a- ‘‘+’’ stands for the wild type while ‘‘2’’ indicates the deletion).
doi:10.1371/journal.pgen.1000909.t002
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portion of the secretory vesicle-specific binding domains of the
globular tail, would likely impair binding of myosin Va to those
cargo organelles bearing the appropriate receptors [18]. Although
this truncation leaves intact the melanocyte specific alternative
exon, exon F, it has been previously shown that binding function is
nonetheless destroyed without the cooperative action of down-
stream motifs [19]. Additionally, the quantity of MYO5A protein
may be significantly reduced, as is often observed in experimen-
tally truncated constructs of this gene [19]. The resulting loss of
vesicle traffic could easily interfere with the normal function of
melanocytes and neurons. The neurologic deficits exhibited by
LFS affected foals are relatively more severe than the symptoms
reported in human cases of Griscelli Syndrome, which are most
often due to changes in a single amino acid rather than loss of a
significant portion of the transcript [16]. However, in the mouse a
broad spectrum of phenotypes are observed, owing to the variety
of causative mutations available for study.
There is some speculation that a mild, survivable epileptic
condition of young foals may represent a non-lethal phenotype of
LFS carriers [2] as the two conditions are often seen in the same
pedigrees. However, this association has not been scientifically
validated and samples from horses diagnosed with this condition
were not available for study at this time. Based on comparative
phenotypes in the mouse this is a plausible scenario. Several
MYO5A alleles in the mouse, most notably mutations of the
globular tail region like d-n and d-n2J, exhibit neurological and
behavioral defects in juvenile homozygotes [20]. These deficits
improve with age and are often survivable, as has been described
in the rumored condition of the horse. Discovery of the mutation
responsible for LFS will enable future studies to evaluate
association of this allele with juvenile neurological dysfunction.
Our results suggest the population frequency of carriers of this
deletion is 10.3% in the Egyptian Arabian. It is possible that this
may be an over estimation of carriers, as owners who suspect they
have LFS carrying horses may have been more motivated to
participate in the study. However it is equally as likely that this
figure is an underestimation as there is social stigma associated
with producing LFS foals, thus motivating breeders to hide the
carrier status of their breeding stock. Despite strict policies
regarding the confidential nature of identifying information in
research projects, this still influences some breeders to avoid
association with Lavender Foal Syndrome research out of fear of
being rumored to own carrier horses. Notably, three of the six
carriers identified were reported to be breeding stallions. Data
from the Egyptian Arabian horse registry indicates that approx-
imately 850 young horses are registered each year (personal
communication, Beth Minnich, Pyramid Society). Given our
estimate of the number of carriers in the population we expect that
around nine LFS foals would be born in the US each year. This is
a small number; however rumors of carrier status can very quickly
negatively impact the breeding career of high-priced stallions and
lead to large economic losses. This estimate also assumes mating at
random. In the case of the Egyptian Arabian horse this is not a
realistic assumption given the commonplace use of inbreeding and
line-breeding in the industry. The allele frequency for LFS of 5.2%
is not unlike the frequencies of other heritable diseases in various
breeds of horse [21,22].
We identified a conserved block of 1.6 Mb in common in the
four LFS bearing haplotypes. This is somewhat smaller than would
be expected considering the average rate of decay of LD across just
the six to eight generations that separate these four haplotypes.
Indeed, upon further research of the pedigrees from carriers
identified during screening for the LFS allele in our sample of 107
Arabian horses, we identified carriers who did not possess this
candidate founder in their pedigree. Therefore it is likely the true
founder of this mutation occurred far earlier. The appearance of a
more recent common ancestor is not surprising given the prolific
use of popular sires and the prevalence of inbreeding in this
population.
Prevention of the economic and emotional losses associated with
lethal conditions in foals, included those affected with LFS is a
high priority among Arabian breeders. The market for Egyptian
Arabian horses particularly values certain popular bloodlines. This
leads to close breeding as owners seek to increase the percentage of
this ancestry in their foal crop. This breeding strategy thus
increases the need for vigilant prevention of recessive genetic
disorders. The test developed here will be a pivotal tool for
breeders seeking to breed within lines segregating for LFS, yet
minimize or eliminate the production of affected foals.
Widespread application of the EquineSNP50 chip in genetic
research is just beginning. In the case of Lavender Foal Syndrome,
the limited availability of samples had impeded the progress of
research using existing mapping tools for many years. Although
whole genome association using large numbers of SNP markers is
heralded as a tool for complex, polygenic traits, here we have
shown that it can be very successfully applied to a simple trait in a
small number of individuals. This work is the first use of the
EquineSNP50 genotyping chip to successfully identify a causative
mutation. While whole genome association is often the tool of
choice for mapping complex traits and QTLs, we have
demonstrated that it can also be a much anticipated solution for
simple traits that face additional challenges in phenotyping and/or
sample number. Testing for the LFS allele will be a valuable aid to
breeders seeking to avoid losing foals while still using many of the
popular lines that may carry Lavender Foal Syndrome. As the
Arabian horse was used to develop many of the modern light horse
breeds it is possible that the LFS allele is present in these breeds as
well. In future work we will test additional sub-types of Arabian, as
well as a variety of light horse breeds to better assess the
population frequency in these groups. It is possible that LFS
segregates in these groups at a low frequency without detection, as
it is easy to confuse with other neonatal disorders of the foal.
Materials and Methods
Ethics Statement
Procedures in living animals were limited to the collection of
blood by jugular venipuncture or hairs pulled from the mane or
tail. Both procedures were conducted according to standard
veterinary protocol and inflict minimal, if any pain. All samples
were voluntarily submitted by horse owners and/or attending
veterinarians to the Antczak or Brooks laboratories according to
protocols approved by the Cornell Institutional Animal Care and
Use Committee protocol #1986-0216.
Table 3. Frequency of the Lavender Foal Syndrome
associated deletion among a sample of Arabian horses.
Genotypes
a +/+ +/2 2/2 LFS Allele Freq.
Egyptian Arabian 52 6 0 0.052
Other Arabian 55 1 0 0.0089
Total 107 7 0 0.031
(a- ‘‘+’’ stands for the wild type while ‘‘2’’ indicates the deletion.
doi:10.1371/journal.pgen.1000909.t003
A MYO5A Deletion Leads to Lavender Foal Syndrome
PLoS Genetics | www.plosgenetics.org 5 April 2010 | Volume 6 | Issue 4 | e1000909Horses
Six initial samples from affected foals plus one foal obtained
mid-way through the study, their 31 relatives, as well as 114
individual horses from the general Arabian horse population were
available for study. The diagnosis of Lavender Foal Syndrome was
made by the attending veterinarian and was consistent with the
previously published case reports [2,3]. Population samples were
voluntarily submitted by horse owners from across the US. As
multiple samples received from a single owner often included
closely related individuals, these horses were selected so as no
horse included in the study was related to any other within a single
generation. Although the identity and pedigree of study horses
were made available, those data are not provided here to protect
confidentiality. Each of the six affected horses had unique parents,
although they were often related farther back in the pedigree
(Figure S1). Samples were coded numerically during use to protect
the anonymity of participating farms and owners.
Sample Collection and Experimental Strategy
Although Lavender Foal Syndrome is widely-known among
breeders of Arabian horses, the number of documented cases
available for study and genetic analysis is very low. The six affected
foals and their 30 relatives used for SNP genotyping in this study
were collected over a 9 year period from Arabian breeders in
various locations in the US. The average SNP density in the horse
has been estimated at 1 per 2,000 bp [9]. It has been proposed
that 100,000 SNPs should be sufficient for genome wide
association mapping in the horse, given the moderate level of
linkage disequilibrium both within and across breeds [9]. Due to
the small number of available affected horses and the smaller than
optimal horse SNP chip (only 56K SNPs), we decided to employ a
modified family study using all of the available affected foals and
their closest relatives, plus extensive pedigrees information
available from the Arabian Horse DataSource (Arabian Horse
Association, Aurora CO).
DNA Extraction
Genomic DNA was isolated from fresh or frozen tissue or
peripheral blood lymphocytes using the DNeasy Blood and Tissue
kit (Qiagen Inc., Valencia, CA) following the manufacturer’s
protocol. DNA was eluted, as well as diluted in, MilliQ (Millipore
Corp., Billerica, MA) water before use in downstream applica-
tions. Hair lysates were prepared for PCR from hair bulbs as
previously published [23].
Pedigree Analysis
The Lineage v.1.06 pedigree analysis program (Personal
Communication, John Pollack, Animal Breeding Group Cornell
University) was used to construct a pedigree and calculate Fi
statistics as well as the coancestry coefficient for the 36 horses
submitted for genotyping (Figure S1). For Figure S1 the ‘‘prune’’
option was used to hide individuals with fewer than two offspring
as well as those with no known ancestors in order to simplify the
pedigree for easier viewing.
EquineSNP50 Genotyping and Analysis
We selected six affected foals, seven of their parents (all those
from which samples were available) and 23 close relatives from
amongst banked samples held at the Antczak laboratory.
Genotyping on the EquineSNP50 chip was performed by the
Genotyping Shared Resource at the Mayo Clinic, (Rochester,
MN) using 75 mL of approximately 75 ng/mL genomic DNA.
Across the 36 samples the genotyping call rate averaged 98% with
a minor allele frequency of 0.47, on average. Genotypes were
filtered to remove SNPs with a MAF ,0.05 and missingness .0.5
using the Plink Whole Genome Analysis Toolset [24]. A Fisher’s
exact 362 test for a significant genotypic association between each
SNP and the affected status was performed using the R statistical
package v2.8.1 [25]. Statistical results were visualized and LD
plots generated using Haploview [26] or the JMP v7.0 software
package (SAS Institute Inc., Cary, NC). 281 SNPs from the
significantly associated region were phased in to haplotypes using
the Phase v2.1.1 [27]. Genome wide LD was estimated using the
r
2 statistic in the Plink Whole Genome Analysis Toolset under the
following filters: minor allele frequency ,0.05 and deviation from
Hardy Weinburg Equilibrium p,0.0001. Ten individuals previ-
ously genotyped on the EquineSNP50 chip were chosen from the
Arabian, Thoroughbred and Saddlebred breeds and compared to
ten unrelated founder Egyptian Arabians typed for this study.
Values were binned in groups of 5000 and average r
2 and inter
SNP distance graphed using Excel 2007 (Microsoft Corp., New
York, NY).
MYO5A Sequencing
As no full length mRNA sequence is currently available for
MYO5A in the horse, exons were identified based on homology to
the human mRNA sequence (NM_000259) aligned in the UCSC
Genome Browser [28]. This human transcript, comprising 12,238
nt of mRNA (spanning 114 kb of genomic sequence) encoding
1855 amino acids, is 97.9% identical to the homologous equine
sequence. Primers spanning these 39 exons were designed based
on the EquCab2.0 genomic sequence from the UCSC Genome
Browser using the Primer3 software [29] and purchased from
Integrated DNA Technologies (Coralville, IA). These primers and
their optimal annealing conditions are listed in Table S1. PCR
products were submitted to the Cornell Core Life Sciences
Laboratories Center for sequencing using standard ABI chemistry
on a 3730 DNA Analyzer (Applied Biosystems Inc., Foster City,
CA). All sequences were submitted to Genbank under the
following accession numbers: GU183550 and GU183551. Se-
quences were aligned and screened for mutations using the Contig
Express program in the Vector NTI Advance v10 suite (Invitrogen
Corp., Carlsbad CA) or the CodonCode Aligner (CodonCode
Corp., Dedham, MA)(Figure S3). The exon 30 sequence from an
LFS horse was translated using Vector NTI Advance v10 and a
multiple alignment constructed in Clustal X v.2 [30] using the
following amino acid sequences from Genbank: horse
XP_001918220.1, human EAW77447.1, mouse CAX15575.1,
dog XP_535487.2, cow XP_615219.4, possum XP_001380677.1,
chicken CAA77782.1, zebrafish AAI63575.1.
PCR–RFLP Detection
25 ng of genomic DNA or 2 mL of hair lysate were amplified by
PCR using the following primers: Myo5a.Exon30.RFLP.F 59-
CAG GGC CTT TGA GAA CTT TG-39 and Myo5a.Exon30.R
59-CAG CCA TGA AAG ATG GGT TT-39. Reactions were
assembled in a 10 mL total volume using FastStart Taq DNA
Polymerase and included all reagents per the manufacturers
recommended conditions (Roche Diagnostics, Indiananpolis, IN).
Thermocycling on an Eppendorf Mastercycler Ep Gradient
(Eppendorf Corp., Westbury, NY) was also according to the
manufacturer’s recommendations with an annealing temperature
of 60uC and a total of 40 cycles for this primer pair. The restriction
digest used 10 mL of PCR product, 1.5 units Fau I (New England
Biolabs Inc. (NEB), Ipswitch, MA), 1x NEB Buffer 4 and enough
MilliQ water to bring the reaction volume to 20 uL. Digests were
incubated at 55uC for 1 hour. The resulting products were
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separated alongside a size standard (100 bp DNA Ladder, NEB)
by electrophoresis following standard conditions on a 3% agarose
gel (Omnipur Agarose, EMD Chemicals Inc, Gibbstown, NJ).
Agarose gels were stained (SYBRsafe DNA gel stain (10,000X)
concentrate, Invitrogen Molecular Probes, Eugene, OR) and
visualized under UV illumination (FluroChem HD2, Alpha
Innotec Corp., San Leandro CA).
Supporting Information
Figure S1 Pedigree of horses used in this study. Red indicates
affected, blue indicates carriers, and green highlights horses chosen
for genotyping.
Found at: doi:10.1371/journal.pgen.1000909.s001 (0.10 MB TIF)
Figure S2 Average genome-wide LD in four horse breeds. The
Egyptian (sub-group of the Arabian) and the Thoroughbred, both
with a long history of a closed stud book, have relatively long LD
in contrast to the Arabian and Saddlebred breeds.
Found at: doi:10.1371/journal.pgen.1000909.s002 (0.12 MB TIF)
Figure S3 Multiple alignment of MYO5A exon 30 amino acid
sequences from eight diverse species and an LFS horse
demonstrating the high level of conservation in this region of the
gene. The first amino acid changed by the g.138235715del is
marked with a yellow arrow. A star denotes completely conserved
amino acids.
Found at: doi:10.1371/journal.pgen.1000909.s003 (1.12 MB TIF)
Figure S4 Detection of the Lavender Foal Syndrome associated
deletion by PCR-RFLP. Digestion products were visualized by
electrophoresis on a 3% gel under UV illumination following
staining with SYBR green. A lane of size standard is on the far left
followed by (A) a negative control, (B) undigested PCR and the
digestion products in lanes, (C) from a normal horse, (D) a carrier,
and finally (E) an affected foal.
Found at: doi:10.1371/journal.pgen.1000909.s004 (0.35 MB TIF)
Table S1 Primers sequences used to amplify 39 exons of
MYO5A.
Found at: doi:10.1371/journal.pgen.1000909.s005 (0.14 MB
RTF)
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